124 related articles for article (PubMed ID: 34665461)
1. Mast cells and histamine are involved in the neuronal damage observed in a quinolinic acid-induced model of Huntington's disease.
Martínez-Gopar PE; Pérez-Rodríguez MJ; Rodríguez-Manzo G; Garduño-Gutierrez R; Tristán-López L; Angeles-López QD; González-Espinosa C; Pérez-Severiano F
J Neurochem; 2022 Jan; 160(2):256-270. PubMed ID: 34665461
[TBL] [Abstract][Full Text] [Related]
2. Early modulation of the transcription factor Nrf2 in rodent striatal slices by quinolinic acid, a toxic metabolite of the kynurenine pathway.
Colín-González AL; Luna-López A; Königsberg M; Ali SF; Pedraza-Chaverrí J; Santamaría A
Neuroscience; 2014 Feb; 260():130-9. PubMed ID: 24361737
[TBL] [Abstract][Full Text] [Related]
3. Sub-chronic copper pretreatment reduces oxidative damage in an experimental Huntington's disease model.
Martínez-Lazcano JC; Montes S; Sánchez-Mendoza MA; Rodríguez-Páez L; Pérez-Neri I; Boll MC; Campos-Arroyo HD; Ríos C; Pérez-Severiano F
Biol Trace Elem Res; 2014 Dec; 162(1-3):211-8. PubMed ID: 25319005
[TBL] [Abstract][Full Text] [Related]
4. Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease.
Ryu JK; Choi HB; McLarnon JG
Neuroscience; 2006 Sep; 141(4):1835-48. PubMed ID: 16809003
[TBL] [Abstract][Full Text] [Related]
5. Essential fatty acid-rich diets protect against striatal oxidative damage induced by quinolinic acid in rats.
Morales-Martínez A; Sánchez-Mendoza A; Martínez-Lazcano JC; Pineda-Farías JB; Montes S; El-Hafidi M; Martínez-Gopar PE; Tristán-López L; Pérez-Neri I; Zamorano-Carrillo A; Castro N; Ríos C; Pérez-Severiano F
Nutr Neurosci; 2017 Sep; 20(7):388-395. PubMed ID: 26928375
[TBL] [Abstract][Full Text] [Related]
6. Mutant Huntingtin affects toll-like receptor 4 intracellular trafficking and cytokine production in mast cells.
Pérez-Rodríguez MJ; Ibarra-Sánchez A; Román-Figueroa A; Pérez-Severiano F; González-Espinosa C
J Neuroinflammation; 2020 Mar; 17(1):95. PubMed ID: 32220257
[TBL] [Abstract][Full Text] [Related]
7. NAD(P)H oxidase contributes to neurotoxicity in an excitotoxic/prooxidant model of Huntington's disease in rats: protective role of apocynin.
Maldonado PD; Molina-Jijón E; Villeda-Hernández J; Galván-Arzate S; Santamaría A; Pedraza-Chaverrí J
J Neurosci Res; 2010 Feb; 88(3):620-9. PubMed ID: 19795371
[TBL] [Abstract][Full Text] [Related]
8. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.
Hughes PE; Alexi T; Williams CE; Clark RG; Gluckman PD
Neuroscience; 1999; 92(1):197-209. PubMed ID: 10392842
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies.
Santamaría A; Salvatierra-Sánchez R; Vázquez-Román B; Santiago-López D; Villeda-Hernández J; Galván-Arzate S; Jiménez-Capdeville ME; Ali SF
J Neurochem; 2003 Jul; 86(2):479-88. PubMed ID: 12871589
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin E induces VEGF production in mast cells and potentiates their pro-tumorigenic actions through a Fyn kinase-dependent mechanism.
Jiménez-Andrade GY; Ibarra-Sánchez A; González D; Lamas M; González-Espinosa C
J Hematol Oncol; 2013 Aug; 6():56. PubMed ID: 23915951
[TBL] [Abstract][Full Text] [Related]
11. Bilateral quinolinic acid-induced lipid peroxidation, decreased striatal monoamine levels and neurobehavioral deficits are ameliorated by GIP receptor agonist D-Ala
Verma MK; Goel R; Nandakumar K; Nemmani KVS
Eur J Pharmacol; 2018 Jun; 828():31-41. PubMed ID: 29577894
[TBL] [Abstract][Full Text] [Related]
12. Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease.
Ryu JK; Kim SU; McLarnon JG
Exp Neurol; 2004 May; 187(1):150-9. PubMed ID: 15081596
[TBL] [Abstract][Full Text] [Related]
13. Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient Kit
Hargrove L; Kennedy L; Demieville J; Jones H; Meng F; DeMorrow S; Karstens W; Madeka T; Greene J; Francis H
Hepatology; 2017 Jun; 65(6):1991-2004. PubMed ID: 28120369
[TBL] [Abstract][Full Text] [Related]
14. Toxic Synergism Between Quinolinic Acid and Glutaric Acid in Neuronal Cells Is Mediated by Oxidative Stress: Insights to a New Toxic Model.
Pierozan P; Colín-González AL; Biasibetti H; da Silva JC; Wyse A; Wajner M; Santamaria A
Mol Neurobiol; 2018 Jun; 55(6):5362-5376. PubMed ID: 28936789
[TBL] [Abstract][Full Text] [Related]
15. Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum.
Ryu JK; Choi HB; McLarnon JG
Neurobiol Dis; 2005 Nov; 20(2):550-61. PubMed ID: 15916899
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide synthase inhibition prevents acute quinolinate-induced striatal neurotoxicity.
Pérez-Severiano F; Escalante B; Ríos C
Neurochem Res; 1998 Oct; 23(10):1297-302. PubMed ID: 9804286
[TBL] [Abstract][Full Text] [Related]
17. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
[TBL] [Abstract][Full Text] [Related]
18. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III).
Pérez-De La Cruz V; González-Cortés C; Galván-Arzate S; Medina-Campos ON; Pérez-Severiano F; Ali SF; Pedraza-Chaverrí J; Santamaría A
Neuroscience; 2005; 135(2):463-74. PubMed ID: 16111817
[TBL] [Abstract][Full Text] [Related]
19. Unique populations of lung mast cells are required for antigen-mediated bronchoconstriction.
Cyphert JM; Kovarova M; Koller BH
Clin Exp Allergy; 2011 Feb; 41(2):260-9. PubMed ID: 20718780
[TBL] [Abstract][Full Text] [Related]
20. Striatal Protection in nNOS Knock-Out Mice After Quinolinic Acid-Induced Oxidative Damage.
Gerónimo-Olvera C; Tristán-López L; Martínez-Lazcano JC; García-Lara L; Sánchez-Mendoza A; Morales-Martínez A; Hernández-Melesio MA; Arregui L; Ríos C; Pérez-Severiano F
Neurochem Res; 2019 Feb; 44(2):421-427. PubMed ID: 30523577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
